220 related articles for article (PubMed ID: 27785428)
1. Risk stratification for kidney sparing procedure in upper tract urothelial carcinoma.
Khene ZE; Mathieu R; Kammerer-Jacquet SF; Seisen T; Roupret M; Shariat SF; Peyronnet B; Bensalah K
Transl Androl Urol; 2016 Oct; 5(5):711-719. PubMed ID: 27785428
[TBL] [Abstract][Full Text] [Related]
2. Upper urinary tract disease: what we know today and unmet needs.
Mathieu R; Bensalah K; Lucca I; Mbeutcha A; Rouprêt M; Shariat SF
Transl Androl Urol; 2015 Jun; 4(3):261-72. PubMed ID: 26816829
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis and kidney-sparing treatments for upper tract urothelial carcinoma: state of the art.
Territo A; Foerster B; Shariat SF; Rouprêt M; Gaya JM; Palou J; Breda A
Minerva Urol Nefrol; 2018 Jun; 70(3):242-251. PubMed ID: 29392926
[TBL] [Abstract][Full Text] [Related]
4. Urothelial cancer of the upper urinary tract: emerging biomarkers and integrative models for risk stratification.
Mathieu R; Vartolomei MD; Mbeutcha A; Karakiewicz PI; Briganti A; Roupret M; Shariat SF
Minerva Urol Nefrol; 2016 Aug; 68(4):381-95. PubMed ID: 27124417
[TBL] [Abstract][Full Text] [Related]
5. Oncologic Outcomes of Kidney-sparing Surgery Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the EAU Non-muscle Invasive Bladder Cancer Guidelines Panel.
Seisen T; Peyronnet B; Dominguez-Escrig JL; Bruins HM; Yuan CY; Babjuk M; Böhle A; Burger M; Compérat EM; Cowan NC; Kaasinen E; Palou J; van Rhijn BW; Sylvester RJ; Zigeuner R; Shariat SF; Rouprêt M
Eur Urol; 2016 Dec; 70(6):1052-1068. PubMed ID: 27477528
[TBL] [Abstract][Full Text] [Related]
6. Ureteroscopic and percutaneous management of upper tract urothelial carcinoma (UTUC): systematic review.
Cutress ML; Stewart GD; Zakikhani P; Phipps S; Thomas BG; Tolley DA
BJU Int; 2012 Sep; 110(5):614-28. PubMed ID: 22471401
[TBL] [Abstract][Full Text] [Related]
7. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 Update.
Rouprêt M; Babjuk M; Compérat E; Zigeuner R; Sylvester RJ; Burger M; Cowan NC; Gontero P; Van Rhijn BWG; Mostafid AH; Palou J; Shariat SF
Eur Urol; 2018 Jan; 73(1):111-122. PubMed ID: 28867446
[TBL] [Abstract][Full Text] [Related]
8. Risk-adapted strategy for the kidney-sparing management of upper tract tumours.
Seisen T; Colin P; Rouprêt M
Nat Rev Urol; 2015 Mar; 12(3):155-66. PubMed ID: 25708579
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors and predictive tools for upper tract urothelial carcinoma: a systematic review.
Mbeutcha A; Rouprêt M; Kamat AM; Karakiewicz PI; Lawrentschuk N; Novara G; Raman JD; Seitz C; Xylinas E; Shariat SF
World J Urol; 2017 Mar; 35(3):337-353. PubMed ID: 27101100
[TBL] [Abstract][Full Text] [Related]
10. Risk stratification for upper tract urinary carcinoma.
Benamran D; Seisen T; Naoum E; Vaessen C; Parra J; Mozer P; Shariat SF; Rouprêt M
Transl Androl Urol; 2020 Aug; 9(4):1799-1808. PubMed ID: 32944543
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors in upper urinary tract urothelial carcinomas: a comprehensive review of the current literature.
Lughezzani G; Burger M; Margulis V; Matin SF; Novara G; Roupret M; Shariat SF; Wood CG; Zigeuner R
Eur Urol; 2012 Jul; 62(1):100-14. PubMed ID: 22381168
[TBL] [Abstract][Full Text] [Related]
12. Why are upper tract urothelial carcinoma two different diseases?
Szarvas T; Módos O; Horváth A; Nyirády P
Transl Androl Urol; 2016 Oct; 5(5):636-647. PubMed ID: 27785420
[TBL] [Abstract][Full Text] [Related]
13. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update.
Rouprêt M; Babjuk M; Compérat E; Zigeuner R; Sylvester RJ; Burger M; Cowan NC; Böhle A; Van Rhijn BW; Kaasinen E; Palou J; Shariat SF
Eur Urol; 2015 Nov; 68(5):868-79. PubMed ID: 26188393
[TBL] [Abstract][Full Text] [Related]
14. Predictive models and prognostic factors for upper tract urothelial carcinoma: a comprehensive review of the literature.
Mbeutcha A; Mathieu R; Rouprêt M; Gust KM; Briganti A; Karakiewicz PI; Shariat SF
Transl Androl Urol; 2016 Oct; 5(5):720-734. PubMed ID: 27785429
[TBL] [Abstract][Full Text] [Related]
15. Nephron-sparing approaches in the management of upper tract urothelial carcinoma: indications and clinical outcomes.
Ko YH
Transl Cancer Res; 2020 Oct; 9(10):6589-6595. PubMed ID: 35117269
[TBL] [Abstract][Full Text] [Related]
16. Urothelial carcinoma of the bladder and the upper tract: disparate twins.
Green DA; Rink M; Xylinas E; Matin SF; Stenzl A; Roupret M; Karakiewicz PI; Scherr DS; Shariat SF
J Urol; 2013 Apr; 189(4):1214-21. PubMed ID: 23023150
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC).
Soria F; Shariat SF; Lerner SP; Fritsche HM; Rink M; Kassouf W; Spiess PE; Lotan Y; Ye D; Fernández MI; Kikuchi E; Chade DC; Babjuk M; Grollman AP; Thalmann GN
World J Urol; 2017 Mar; 35(3):379-387. PubMed ID: 27604375
[TBL] [Abstract][Full Text] [Related]
18. Endoscopic management of upper-tract urothelial carcinoma.
Raman JD; Park R
Expert Rev Anticancer Ther; 2017 Jun; 17(6):545-554. PubMed ID: 28480774
[TBL] [Abstract][Full Text] [Related]
19. Kidney sparing surgery for upper-tract urothelial carcinoma.
Raman JD
Minerva Urol Nefrol; 2016 Aug; 68(4):359-71. PubMed ID: 27058053
[TBL] [Abstract][Full Text] [Related]
20. Risk stratification of upper tract urothelial carcinoma: A Review of the Current Literature.
Kardoust Parizi M; Glybochko PV; Enikeev D; Rouprêt M; Fajkovic H; Seebacher V; Shariat SF
Expert Rev Anticancer Ther; 2019 Jun; 19(6):503-513. PubMed ID: 31131643
[No Abstract] [Full Text] [Related]
[Next] [New Search]
